DNA Methylation of BRCA1, BRCA2, and TP53 Promoters as Biomarker for the Early Diagnosis of Simian Virus 40-Related Breast Carcinoma

被引：0
|
作者：
Soukayna Alaoui Sosse
Kaoutar Anouar Tadlaoui
Imane Saif
Mustapha Benhassou
Mohamed Elkarroumi
Moulay Mustapha Ennaji
机构：
[1] University Hassan II of Casablanca,Team of Virology, Oncology and Biotechnology, Laboratory of Virology, Oncology, Biosciences, Environment and New Energies, Faculty of Sciences and Techniques‐Mohammedia
[2] University Hassan II of Casablanca,School of Medicine and Pharmacy
来源：
Indian Journal of Gynecologic Oncology | 2024年 / 22卷
关键词：
Breast cancer; Methylation; Viral infection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] DNA Methylation of BRCA1, BRCA2, and TP53 Promoters as Biomarker for the Early Diagnosis of Simian Virus 40-Related Breast Carcinoma
    Sosse, Soukayna Alaoui
    Tadlaoui, Kaoutar Anouar
    Saif, Imane
    Benhassou, Mustapha
    Elkarroumi, Mohamed
    Ennaji, Moulay Mustapha
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 22 (01)
  • [2] Allelic loss at the BRCA1, BRCA2 and TP53 loci in human sporadic breast carcinoma
    Katsama, A
    Sourvinos, G
    Zachos, G
    Spandidos, DA
    CANCER LETTERS, 2000, 150 (02) : 165 - 170
  • [3] Alterations in BRCA1, BRCA2, TP53 and ATM genes in sporadic breast tumours
    Prokopcova, J.
    Soukupova, J.
    Ticha, I.
    Janatova, M.
    Sevcik, J.
    Kleibl, Z.
    Kleiblova, P.
    Pohlreich, P.
    EJC SUPPLEMENTS, 2010, 8 (05): : 203 - 203
  • [4] Preliminary investigation of the promoter methylation status of BRCA1, BRCA2 TP53 genes of some breast cancer patients
    Samuel, Titilola A.
    James, Babatunde Ayo
    Habeeb, Muhammad
    Oshodi, Temitope
    Magbagbeola, Olubunmi
    CANCER RESEARCH, 2016, 76
  • [5] The role of alterations in BRCA1, BRCA2, TP53 and ATM genes in sporadic breast tumors
    Ticha, I.
    Soukupova, J.
    Janatova, M.
    Kleibl, Z.
    Pohlreich, P.
    EJC SUPPLEMENTS, 2008, 6 (09): : 118 - 118
  • [6] Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours
    Ramus, SJ
    Bobrow, LG
    Pharoah, PDP
    Finnigan, DS
    Fishman, A
    Altaras, M
    Harrington, PA
    Gayther, SA
    Ponder, BAJ
    Friedman, LS
    GENES CHROMOSOMES & CANCER, 1999, 25 (02): : 91 - 96
  • [7] BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives
    Lalloo, F
    Varley, J
    Moran, A
    Ellis, D
    O'Dair, L
    Pharoah, P
    Antoniou, A
    Hartley, R
    Shenton, A
    Seal, S
    Bulman, B
    Howell, A
    Evans, DGR
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (08) : 1143 - 1150
  • [8] Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer
    Tseng, SL
    Yu, JC
    Yue, CT
    Chang, SF
    Chang, TM
    Wu, CW
    Shen, CY
    GENES CHROMOSOMES & CANCER, 1997, 20 (04): : 377 - 382
  • [9] Genomic deletions in the BRCA1, BRCA2 and TP53 regions associate with low expression of the estrogen receptor in sporadic breast carcinoma
    Schmutzler, RK
    Bierhoff, E
    Werkhausen, T
    Fimmers, R
    Speiser, P
    Kubista, E
    Krebs, D
    Zeillinger, R
    Wiestler, OD
    VonDeimling, A
    INTERNATIONAL JOURNAL OF CANCER, 1997, 74 (03) : 322 - 325
  • [10] EGFR, BRCA1, BRCA2 and TP53 genetic profile in Moroccan triple negative breast cancer cases
    Jouali, Farah
    El Ansari, Fatima Zahra
    Marchoudi, Nabila
    Barakat, Amina
    Zmaimita, Hassaniya
    Samlali, Hamza
    Fekkak, Jamal
    INTERNATIONAL JOURNAL OF MOLECULAR EPIDEMIOLOGY AND GENETICS, 2020, 11 (01): : 16 - 25
12345